Washington [US], April 22 (ANI): Filming for the latest episode of 'The Late Show' has been cancelled after its host Stephen Colbert tested positive for the COVID-19 virus.
New Delhi [India], April 22 (ANI): The trials designed by the researchers at the Indian Institute of Technology (IIT) Madras have has shown the excellent efficacy of Indomethacin, a non-steroidal anti-inflammatory drug, as an antiviral agent in the treatment of mild and moderate COVID-19 pat
New Delhi [India], April 22 (ANI): With COVID cases rising in the national capital, the Delhi government on Friday issued new Standard Operating Procedure for schools.
Taipei [Taiwan], April 22 (ANI/Xinhua): Taiwan on Thursday recorded 3,766 new locally transmitted COVID-19 cases and 93 imported cases, according to the island's disease monitoring agency said Friday.
New Delhi [India], April 22 (ANI/PRNewswire): Praised by Nobel laureates and other economists of global renown, The Resilient Society is a timely and topical book.
New Delhi [India], April 22 (ANI): The Ministry of Health and Family Welfare informed on Friday that over 192.40 crores COVID-19 vaccine doses have been provided to States and Union Territories so far.
Kathmandu [Nepal], April 22 (ANI): Secondary Education Examination (SEE) in Nepal started on Friday with students appearing in person as the COVID-19 wave in the Himalayan Nation continues to falter.
New Delhi [India], April 22 (ANI): India's COVID-19 cases continue to rise as the country reported 2,451 fresh COVID-19 cases (71 cases higher than yesterday) with 54 fatalities on Friday.
London[UK], April 22 (ANI): The inaugural Indo-Pacific Dialogue hosted by the Indo-Pacific All-Party Parliamentary Groups (APPG) was held in the UK parliament on Tuesday. This was the first physical meeting, post the Covid restrictions.
Austin (Texas) [US], April 22 (ANI/PRNewswire): Direct Biologics, a regenerative biotechnology company with a groundbreaking extracellular vesicle (EV) platform technology, announced today that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigatio
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.